BridgeBio Pharma, Inc.BBIONASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
-1.05%
↑ 98% above average
Average (30q)
-53.35%
Historical baseline
Range
High:95.02%
Low:-1388.10%
Volatility
-2780.2%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | -1.05% |
| Q2 2025 | -7.95% |
| Q1 2025 | 37.14% |
| Q4 2024 | -62.79% |
| Q3 2024 | -120.51% |
| Q2 2024 | -95.00% |
| Q1 2024 | 79.17% |
| Q4 2023 | 11.11% |
| Q3 2023 | -10.20% |
| Q2 2023 | -6.52% |
| Q1 2023 | 11.54% |
| Q4 2022 | -4.00% |
| Q3 2022 | -1388.10% |
| Q2 2022 | 95.02% |
| Q1 2022 | -33.66% |
| Q4 2021 | 4.72% |
| Q3 2021 | -60.61% |
| Q2 2021 | 44.07% |
| Q1 2021 | -16.83% |
| Q4 2020 | -3.06% |
| Q3 2020 | 4.85% |
| Q2 2020 | -32.05% |
| Q1 2020 | -25.81% |
| Q4 2019 | -21.57% |
| Q3 2019 | 28.17% |
| Q2 2019 | -39.22% |
| Q1 2019 | -21.43% |
| Q4 2018 | -23.53% |
| Q3 2018 | -17.24% |
| Q2 2018 | 21.62% |
| Q1 2018 | 0.00% |